Berry Global Group, Inc. has announced that phase one of its three phase, $20 million Sof-Flex film expansion plan is on track to be operational in December 2020. The investment —initially announced in January— will span Berry’s U.S.-based network of breathable film producing plants and is scheduled to be completed by 2022.

As reported earlier this year, the company’s investment addresses both extrusion and printing capabilities, in support of growing breathable film and sustainable product market demands in the North American region. The investment will include added capacity for Berry’s proprietary Sof-Flex technology and the addition of the newest flexographic printing equipment. The Sof-Flex technology allows for the sustainable, down-weighting of breathable films while maintaining best-in-class performance.

“We are excited to expand our Sof-Flex breathable film capacity. Our patent protected technology enhances hygiene and healthcare products across the globe. From sustainable and cost effective solutions through light-weight product designs, to new breathable functionality in incontinence products, Sof-Flex enables our customers to achieve their most critical product performance objectives.” says Robert Weilminster, EVP and GM, for Berry’s hygiene markets in the U.S.  and Canada.

In support of new business awards beyond the scope of the three phase expansion plan, Berry is pleased to also announce the investment and start-up of a second flexographic printing line with unique embossing capabilities in 2020.